BioAtla, Inc.

BCAB Stock Healthcare Biotechnology
$1.74
-1.41 (-44.75%)
Price as of Aug 28, 2026 market close

Performance

1 Month
-48.7%
3 Months
-55.9%
YTD
-93.9%
1 Year
-92.2%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
139.8%
Largest decline max drawdown, since Aug 2025
-97.2%
Risk-adjusted return Sharpe ratio, 1-year
-1.08

Own BCAB?

See how BCAB contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.